RESEARCH COLLABORATION AND OPTION AGREEMENTResearch Collaboration and Option Agreement • May 2nd, 2019 • Seres Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This RESEARCH COLLABORATION AND OPTION AGREEMENT (the “Agreement”) is made as of the date of last signature hereunder (the “Effective Date”), by and between MedImmune, LLC., a limited liability company organized and existing under the laws of Delaware, having an office located at One MedImmune Way Gaithersburg, MD 20878, USA (“MedImmune”), and Seres Therapeutics, Inc., a corporation incorporated and existing under the laws of the State of Delaware, having an office located at 200 Sidney Street, Cambridge, MA 02139, USA (“Seres”). MedImmune and Seres are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
